FibroBiologics announces newly issued U.S. patent for disc regeneration methods
FibroBiologics says a newly issued U.S. patent covers methods of promoting disc regeneration using components derived from stimulated fibroblasts.
Newly Issued Patent Covers Methods of Promoting Disc Regeneration Using Components Derived from Stimulated FibroblastsHOUSTON, Sept.
1, 2026 // -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics" or the "Company"), a clinical-stage biotechnology company with 270+ patents issued and p…